Principal Formulation Scientists – Biopharmaceutical Products
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Ballerup
Are you a biopharmaceutical scientist with experience of formulation development and aseptic fill & finish processes for proteins and interested in a job with impact, exciting scientific challenges and the opportunity to use and develop your strategic mindset? Then this may be just the job for you!
LEO Pharma has embarked on a growth journey to become the preferred dermatology care partner in the World, dedicated to help people achieve healthy skin. We have an ambitious 2030 strategy, which aims to accelerate our impact in innovative therapeutics while strengthening our established portfolio and our global footprint in medical dermatology. Dermatology is an area of rapid growth and LEO Pharma´s vision is to reach 125 mill. patients worldwide by 2025. Biopharmaceutical Products is one of two departments (the other being Biopharmaceutical Processes) within LEO focusing on the CMC development of biologics. The departments were started in 2017 with a strong focus on building biologics CMC capabilities within LEO to support a growing pipeline of monoclonal antibodies (mAbs). This is why we need you!
The job
In Biopharmaceutical Products you will join 17 highly skilled and experienced persons constituted by Formulation and Analytical Scientists and Technicians, all with the focus of developing biologics products from discovery to market as well as supporting commercial manufacturing and post launch activities (LCM). All projects are run as external partnerships with extensive CDMO/CRO collaborations. The department is responsible for all CMC product activities throughout the full value chain for monoclonal antibodies including; developability studies, development of formulations and analytical methods, module 3 documentation, feasibility studies and IMP productions.
As the principal formulation scientist your essential tasks will be:
Qualifications
We expect the ideal candidate to
Additional information
For additional information, please contact Senior Manager Christer Andersson [email protected] +45 3138 5986 or Senior Manager Kristoffer Toemmeraas, [email protected]. Send your application and CV in English as soon as possible and no later than 3 January 2021 as we will review incoming applications on an on-going basis.
About LEO Pharma
LEO Pharma is on an exciting journey of transformation to become the world leader in dermatology. We keep the patients at the heart of everything we do, and we drive dermatology with our knowledge, collaboration and curiosity. We are at the forefront of science in developing new medicines for dermatology, and we are committed to helping people with skin diseases live more fulfilling lives.
Our people are united worldwide with strong core values and a common vision. Our shared vision and mission adapt to an ever-changing environment, while remaining true to our business strategy. Our values reflect the way we strive to increase the quality of life for patients.
Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions. LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 92 million patients in 130 countries.
LEO Pharma has embarked on a growth journey to become the preferred dermatology care partner in the World, dedicated to help people achieve healthy skin. We have an ambitious 2030 strategy, which aims to accelerate our impact in innovative therapeutics while strengthening our established portfolio and our global footprint in medical dermatology. Dermatology is an area of rapid growth and LEO Pharma´s vision is to reach 125 mill. patients worldwide by 2025. Biopharmaceutical Products is one of two departments (the other being Biopharmaceutical Processes) within LEO focusing on the CMC development of biologics. The departments were started in 2017 with a strong focus on building biologics CMC capabilities within LEO to support a growing pipeline of monoclonal antibodies (mAbs). This is why we need you!
The job
In Biopharmaceutical Products you will join 17 highly skilled and experienced persons constituted by Formulation and Analytical Scientists and Technicians, all with the focus of developing biologics products from discovery to market as well as supporting commercial manufacturing and post launch activities (LCM). All projects are run as external partnerships with extensive CDMO/CRO collaborations. The department is responsible for all CMC product activities throughout the full value chain for monoclonal antibodies including; developability studies, development of formulations and analytical methods, module 3 documentation, feasibility studies and IMP productions.
As the principal formulation scientist your essential tasks will be:
- Setting development strategies for activities associated with our mAb products
- Participate in CMC teams and project work. Collaborate with team members from different departments within development
- Lead, plan and document development work related to formulations and manufacturing processes for proteins, including GMP manufacturing, process scale-up/optimization using Quality by Design principles and validation activities at contract manufacturers
- Manage selection and oversight of contract manufacturers (CDMOs)
- Coordinate activities at contract laboratories and contract manufacturers assuring adherence to agreed timelines
- Lead transfer of technology activities to third party manufacturers
- Write, elaborate and contribute to relevant regulatory documents
- Initiate/introduce new scientific know-how and keep an updated scientific and regulatory knowledge in the areas of formulation development, pharmaceutical manufacturing and process scale-up/validation
- Coach and train colleagues within formulation / Fill& Finish activities for Biologics
Qualifications
We expect the ideal candidate to
- Have minimum a M.Sc. in pharmaceutical sciences, chemical engineering or equivalent education preferable a Ph.D.
- Have well founded and relevant experience from biopharmaceutical industry
- Have proven scientific skills in formulation development and/or process scale-up, primarily within aseptic/sterile technology preferable also freeze-drying formulations
- Have experience in outsourcing and coordinating activities with CDMO/CROs
- Be familiar with GMP and have experience in pharmaceutical manufacturing
- Be able to obtain a good overview, prioritize and take full responsibility of an assignment
- Be innovative, flexible and quality minded
- Have excellent communication skills and be fluent in English, both spoken and written
Additional information
For additional information, please contact Senior Manager Christer Andersson [email protected] +45 3138 5986 or Senior Manager Kristoffer Toemmeraas, [email protected]. Send your application and CV in English as soon as possible and no later than 3 January 2021 as we will review incoming applications on an on-going basis.
About LEO Pharma
LEO Pharma is on an exciting journey of transformation to become the world leader in dermatology. We keep the patients at the heart of everything we do, and we drive dermatology with our knowledge, collaboration and curiosity. We are at the forefront of science in developing new medicines for dermatology, and we are committed to helping people with skin diseases live more fulfilling lives.
Our people are united worldwide with strong core values and a common vision. Our shared vision and mission adapt to an ever-changing environment, while remaining true to our business strategy. Our values reflect the way we strive to increase the quality of life for patients.
Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions. LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 92 million patients in 130 countries.
Information og data
Denne ledige stilling har jobtypen "Forsker", og befinder sig i kategorien "Sundhed og forskning".
Arbejdsstedet er beliggende i Ballerup.
Jobbet er oprettet på vores service den 30.10.2020, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forsker
- Ballerup
- Mandag den 04. januar 2021
Lignende jobs
-
Senior Clinical Research Scientist, Solid Tumor Te...
At [xxxxx], we’re committed to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and th..Få mere info- Forsker
- København
-
Drug Product Scientist
Få mere info- Forsker
- Ballerup
-
Adjunkt/Lektor til Kommunikationsuddannelsen på [x...
[xxxxx] søger en underviser til Kommunikationsuddannelsen i Ørestaden.Vil du være med til at uddanne fremtidens talenter til kommunikationsbranchen? Kan du skabe..Få mere info- Forsker
- København S
-
To medarbejdere med ansvar for bæredygtighed og gr...
Vil du være med til at gøre en forskel for den grønne omstilling? Så er det måske lige dig, som vi mangler. På NEXT – Uddannelse København har vi en vision om at være det bedste sted at være og l..Få mere info- Forsker
- Storkøbenhavn
Statistik over udbudte jobs som forskere i Ballerup
Herunder ser du udviklingen i udbudte forsker i Ballerup over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forskere.
Se flere statistikker her:
Statistik over udbudte forskere i Ballerup over tid
| Dato | Alle jobs som forskere |
|---|---|
| 19. september 2024 | 5 |
| 18. september 2024 | 4 |
| 17. september 2024 | 3 |
| 16. september 2024 | 1 |
| 15. september 2024 | 1 |
| 14. september 2024 | 1 |
| 13. september 2024 | 1 |
| 12. september 2024 | 1 |
| 11. september 2024 | 1 |
| 10. september 2024 | 1 |
| 9. september 2024 | 1 |
| 8. september 2024 | 1 |
| 7. september 2024 | 1 |
| 6. september 2024 | 1 |
| 5. september 2024 | 1 |
| 4. september 2024 | 3 |
| 3. september 2024 | 3 |
| 2. september 2024 | 3 |
| 1. september 2024 | 3 |
| 31. august 2024 | 3 |
| 30. august 2024 | 3 |
| 29. august 2024 | 3 |
| 28. august 2024 | 3 |
| 27. august 2024 | 3 |
| 26. august 2024 | 2 |
| 25. august 2024 | 2 |
| 24. august 2024 | 2 |
| 23. august 2024 | 2 |
| 22. august 2024 | 2 |
| 21. august 2024 | 2 |
| 20. august 2024 | 2 |